Petredis Investment Advisors LLC Eli Lilly & CO Transaction History
Petredis Investment Advisors LLC
- $968 Billion
- Q4 2024
A detailed history of Petredis Investment Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Petredis Investment Advisors LLC holds 11,223 shares of LLY stock, worth $9.07 Million. This represents 0.9% of its overall portfolio holdings.
Number of Shares
11,223
Previous 11,442
1.91%
Holding current value
$9.07 Million
Previous $10.1 Billion
14.53%
% of portfolio
0.9%
Previous 1.08%
Shares
14 transactions
Others Institutions Holding LLY
# of Institutions
4,033Shares Held
737MCall Options Held
8.26MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$78.3 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$59.6 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$53.2 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$41.5 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$27.4 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $768B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...